C18 Dihydroceramide (d18:0/18:0)

别名 N-硬脂酰-D-赤型二氢鞘氨醇
英文别名 C18 Dihydroceramide|2304-80-5|N-(octadecanoyl)-sphinganine|N-Stearoylsphinganine|CERAMIDE NG|Cer(d18:0/18:0)|n-stearoyl dihydrosphingosine|N-(stearoyl)-dihydroceramide|C18DH Cer|N-octodecanoylsphinganine|N-(octadecanoyl)-dihydroceramide|Ceramide II|Cerami
规格或纯度 >99%
英文名称 C18 Dihydroceramide (d18:0/18:0) 生化机理 Dihydroceramides act as precursors for ceramides in the mammalian de-novo sphingolipid pathway. vitamin D supplementation increases plasma C18 dihydroceramide (C18-DHC) levels in type 2 diabetes mellitus (T2D) patients. Low serum concentration of C18-DHC has been observed in patients with history of graft rejection and ischemic type biliary lesions (ITBL). Therefore, it can be used as a predictor of graft rejection.
储存温度 -20°C储存
运输条件 超低温冰袋运输
产品介绍 C18 Dihydroceramide (d18:0/18:0) or N-Stearoylsphinganine is a synthetic lipid. Acylation of sphinganine with stearoyl (FA-CoA with C18 acyl chain) by dihydro ceramide synthase 1, yields C18-dihydroceramide. application： C18 Dihydroceramide (d18:0/18:0) has been used as a standard for the quantitation of sphingolipid metabolites in adipose tissues by quadrupole time-of-flight (Q-TOF) mass spectrometry.